Study identifier:D133HR00024
ClinicalTrials.gov identifier:NCT06230328
EudraCT identifier:N/A
CTIS identifier:N/A
Brazilian Reality of Hepatocellular Carcinoma - BRA-HEP: Multicenter Retrospective Study (Real World Evidence - RWE)
Hepatocellular Carcinoma
Phase 4
No
-
All
300
Observational
18 Years - 100 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2024 by AstraZeneca
AstraZeneca
Hospital Israelita Albert Einstein
No locations available
Arms | Assigned Interventions |
---|---|
Cohort 1 Patients with early tumors at diagnosis (BCLC 0, A or B) | - |
Cohort 2 Pacientes com tumores avançados ao diagnóstico (BCLC C ou D) | - |